DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Mobile Imaging
SEARCH
Current Location:
>
> This Story


Log in or Register to rate this News Story
Forward Printable StoryPrint Comment

 

Oncology Homepage

Sectra report addresses value of machine learning in radiology Concept of automatic characterization and scoring of lesions has great support

Philips scores FDA clearance for small parts ultrasound imaging solution Available for EPIQ 7 and 5 and Affiniti 70 systems

Blue Earth Diagnostics inks Axumin deal with Seibersdorf Laboratories Manufacturing and distribution in certain European countries

Two new imaging agents may help physicians make better and quicker treatment decisions Could determine therapy response in 24 hours

Elekta partners with Alliance for Cancer Care The Alliance will replace all radiotherapy tools and services with Elekta products

European surgeons perform world's first super-microsurgery with robotic device Sutured .3 to .8 mm vessels

ASTRO 2017: The four top takeaways 'Plan twice, irradiate once' may well be the radiation oncologist’s mantra

Blue Earth Diagnostics partners with GE to manufacture Axumin PET agent in UK Agreements were made in other European countries

Hypofractionated whole-breast radiotherapy best for early-stage breast cancer patients under 50 Study supports higher dose, shorter form treatment

A clinical look at the Varian Halcyon during ASTRO A visit to the Moores Cancer Center on the UC San Diego campus

Many appendicitis cases may be treatable with antibiotics — but which ones remains unclear

by John W. Mitchell , Senior Correspondent
A U.S. study to determine if a European protocol for treating acute, uncomplicated appendicitis with antibiotics — rather than surgery — is scheduled to commence in 2016. The study has been preceded by a review of six European randomized controlled trials of antibiotic treatment.

The review, to be published next month in the Journal of the American College of Surgeons, found that the European antibiotic treatment is successful in about three out of four patients. But the study found that it is too early to adopt the nonsurgical treatment in the U.S.

Story Continues Below Advertisement

Connecting Vitals Acquisition at the Point of Care

Vital signs acquisition happens countless times a day, but disconnected processes and devices for gathering measurements leave a lot of room for improvement. See how a connected ecosystem helps improve accuracy and efficiency. Click to learn more>



“We wanted to identify evidence gaps that were preventing clinicians from reaching definitive conclusions about the antibiotics-first approach,” Dr. Annie P. Ehlers, lead investigator and a research fellow in the department of surgery at the University of Washington (UW), Seattle, told HCB News. “We wanted to thoroughly review the previously performed studies so that we could design a study in the United States that would address unanswered questions.”

According to UW sources, the U.S study will compare 1,552 patients who will be randomly treated for appendicitis with either antibiotics or the traditional surgical removal. A separate observational cohort of 500 patients who decline randomization will also be separately included in the study as well.

“Many questions are related to patient-centered outcomes such as quality of life among patients treated with antibiotics-first compared to surgery,” said Ehlers. “It was interesting that there was so little information about long-term pain, anxiety, or the amount of time missed from work due to their treatment or due to symptoms that occurred later on.”

She also noted that the one-year follow-up of the European antibiotic studies might not be long enough to consider all future complications, such as cancer. Surgeons and emergency medicine physicians in Washington and California are currently planning the study, which will be funded by The Patient-Centered Outcomes Research Institute. Results are not expected until 2020.

Appendicitis is a relatively common lifetime condition that strikes about seven percent of the population. Some 300,000 Americans undergo appendectomy each year. The role of the appendix, which is about the size of a pinkie finger, is unclear. According to UW sources, some researchers think it promotes good gut bacteria, while other believe the appendage to be a vestigial organ with no function. Surgical removal has been the standard of care for at least 120 years, according to the American College of Surgeons.

“It is unlikely that antibiotics-first will entirely replace surgery in the treatment of acute uncomplicated appendicitis,” explained Ehlers. “But we need to ensure that patients with acute, uncomplicated appendicitis have the most complete information possible when discussing their options with their physician.”

Oncology Homepage


You Must Be Logged In To Post A Comment

Advertise
Increase Your
Brand Awareness
Auctions + Private Sales
Get The
Best Price
Buy Equipment/Parts
Find The
Lowest Price
Daily News
Read The
Latest News
Directory
Browse All
DOTmed Users
Ethics on DOTmed
View Our
Ethics Program
Gold Parts Vendor Program
Receive PH
Requests
Gold Service Dealer Program
Receive RFP/PS
Requests
Healthcare Providers
See all
HCP Tools
Jobs/Training
Find/Fill
A Job
Parts Hunter +EasyPay
Get Parts
Quotes
Recently Certified
View Recently
Certified Users
Recently Rated
View Recently
Certified Users
Rental Central
Rent Equipment
For Less
Sell Equipment/Parts
Get The
Most Money
Service Technicians Forum
Find Help
And Advice
Simple RFP
Get Equipment
Quotes
Virtual Trade Show
Find Service
For Equipment
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2017 DOTmed.com, Inc.
ALL RIGHTS RESERVED